Chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: Are they related?

Current Prostate Reports

Volumn 4, Issue 3, 2006, Pages 141-146

  Pontari, Michel A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BIOLOGICAL MARKER; CIPROFLOXACIN; CLINDAMYCIN; CYCLOSPORIN; DOXYCYCLINE; ERYTHROMYCIN; METRONIDAZOLE; PENTOSAN POLYSULFATE; PLACEBO; RIFAMPICIN;

CHRONIC PROSTATITIS; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; HUMAN; INTERSTITIAL CYSTITIS; PATHOPHYSIOLOGY; PELVIS PAIN SYNDROME; PREVALENCE; QUALITY OF LIFE; REVIEW; SHORT FORM 36; UNSPECIFIED SIDE EFFECT;

EID: 33750343707     PISSN: 15441865     EISSN: 1544225X     Source Type: Journal    
DOI: 10.1007/s11918-006-0027-7     Document Type: Review

References (46)

1. Curhan GC, Speizer FE, Hunter DJ, et al.: Epidemiology of interstitial cystitis: a population based study [see comment]. J Urol 1999, 161:549-552.
2. Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, et al.: Prevalence of interstitial cystitis symptoms in a managed care population. J Urol 2005, 174:576-580.
3. O'Leary MP, Sant GR, Fowler FJ Jr, et al.: The interstitial cystitis symptom index and problem index. Urology 1997, 49:58-63.
4. Nickel JC, Teichman JM, Gregoire M, et al.: Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: the Canadian PIE Study. Urology 2005, 66:935-940.
5. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al.: The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999, 162:369-375.
6. Nickel JC, Siemens DR, Nickel KR, Downey J: The patient with chronic epididymitis: characterization of an enigmatic syndrome [see comment]. J Urol 2002, 167:1701-1704.
7. Nickel JC, Downey J, Hunter D, Clark J: Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol 2001, 165:842-845.
8. Roberts RO, Jacobson DJ, Girman CJ, et al.: Prevalence of prostatitis-like symptoms in a community-based cohort of older men. J Urol 2002, 168:2467-2471.
9. Collins MM, Meigs JB, Barry MJ, et al.: Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 2002, 167:1363-1366.
10. Mehik A, Hellstrom P, Lukkarinen O, et al.: Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int 2000, 86:443-448.
11. Simon LJ, Landis JR, Erickson DR, Nyberg LM: The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology 1997, 49:64-75.
12. Schaeffer AJ, Landis JR, Knauss JS, et al.: Demographic and clinical characteristics of men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study [see comment]. J Urol 2002, 168:593-598.
13. Novi JM, Jeronis S, Srinivas S, et al.: Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case-control study. J Urol 2005, 174:937-940.
14. Weissman MM, Gross R, Fyer A, et al.: Interstitial cystitis and panic disorder: a potential genetic syndrome. Arch Gen Psychiatry 2004, 61:273-279.
15. Pontari MA, McNaughton-Collins M, O'Leary M P, et al.: A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int 2005, 96:559-565.
16. Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233.
17. Tincello DG, Walker AC: Interstitial cystitis in the UK: results of a questionnaire survey of members of the Interstitial Cystitis Support Group. Eur J Obstet Gynecol Reprod Biol 2005, 118:91-95.
18. McNaughton Collins M, Pontari MA, O'Leary MP, et al.: Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network [see comment]. J Gen Intern Med 2001, 16:656-662.
19. Tripp DA, Curtis Nickel J, Landis JR, et al.: Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study. BJU Int 2004, 94:1279-1282. This study examines the factors associated with decreased quality of life in men with CP/CPPS.
20. Lutgendorf SK, Latini JM, Rothrock N, et al.: Autonomic response to stress in interstitial cystitis. J Urol 2004, 172:227-231.
21. Ullrich PM, Turner JA, Ciol M, Berger R: Stress is associated with subsequent pain and disability among men with nonbacterial prostatitis/pelvic pain. Ann Behav Med 2005, 30:112-118.
22. Buffington CA: Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol 2004, 172:1242-1248. This paper outlines the evidence for IC as an aberrant response to stress and reviews the probable biochemical pathways involved.
23. Pontari MA, Ruggieri MR: Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172:839-845.
24. Fitzgerald MP, Koch D, Senka J: Visceral and cutaneous sensory testing in patients with painful bladder syndrome. Neurourol Urodyn 2005, 24:627-632.
25. Ness TJ, Powell-Boone T, Cannon R, et al.: Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis. J Urol 2005, 173:1983-1987.
26. Yang CC, Lee JC, Kromm BG, et al.: Pain sensitization in male chronic pelvic pain syndrome: Why are symptoms so difficult to treat? J Urol 2003, 170:823-827.
27. Propert KJ, Schaeffer AJ, Brensinger CM, et al.: A prospective study of interstitial cystitis: results of longitudinal follow-up of the interstitial cystitis database cohort. The Interstitial Cystitis Database Study Group. J Urol 2000, 163:1434-1439.
28. Propert KJ, McNaughton-Collins M, Leiby B, et al.: A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2006, 175:619-623.
29. Warren JW, Home LM, Hebel JR, et al.: Pilot study of sequential oral antibiotics for the treatment of interstitial cystitis. J Urol 2000, 163:1685-1688.
30. Alexander RB, Propert KJ, Schaeffer AJ, et al.: Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004, 141:581-589
31. (Summary for patients in Ann Intern Med 2004, 141:18).
32. Nickel JC, Forrest JB, Tomera K, et al.: Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo-controlled study. J Urol 2005, 173:1252-1255.
33. Nickel JC, Barkin J, Forrest J, Mosbaugh PG, et al.: Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology 2005, 65:654-658.
34. Palapattu GS, Shoskes DA: Resolution of the chronic pelvic pain syndrome after renal transplantation. J Urol 2000, 164:127.
35. Sairanen J, Forsell T, Ruutu M: Long-term outcome of patients with interstitial cystitis treated with low-dose cyclosporine A. J Urol 2004, 171:2138-2141.
36. Keay S, Zhang CO, Marvel R, Chai T: Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor: sensitive and specific urine markers for interstitial cystitis. Urology 2001, 57(suppl 1):104.
37. Keay S, Zhang CO, Shoenfelt JL, Chai TC: Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis. Urology 2003, 61:1278-1284.
38. Keay S, Seillier-Moiseiwitsch F, Zhang CO, et al.: Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Physiol Genomics 2003, 14:107-115.
39. Keay SK, Szekely Z, Conrads TP, et al.: An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci USA 2004, 101:11803-11808. This important paper describes the chemical structure of APF, the most important biomarker described to date for IC.
40. Jones SE, Jomary C, Grist J, et al.: Modulated expression of secreted frizzled-related proteins in human retinal degeneration. Neuroreport 2000, 11:3963-3967.
41. Schumann H, Holtz J, Zerkowski HR, Hatzfeld M: Expression of secreted frizzled related proteins 3 and 4 in human ventricular myocardium correlates with apoptosis-related gene expression. Cardiovasc Res 2000, 45:720-728.
42. Keay S, Zhang CO, Chai T, et al.: Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome. Urology 2004, 63:22-26.
43. Krieger JN, Nyberg L Jr, Nickel JC: NIH consensus definition and classification of prostatitis. JAMA 1999, 282:236-237.
44. Gillenwater JY, Wein AJ: Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988, 140:203-206.
45. Hanno PM, Landis JR, Matthews-Cook Y, et al.: The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 1999, 161:553-557.
46. Fall M, Baranowski AP, Fowler CJ, et al.: EAU guidelines on chronic pelvic pain. Eur Urol 2004, 46:681-689.